AXON Axon Enterprise
Moat is real and growth persists, but even at 430 the price outruns plausible GAAP margins.
The story
Axon runs a near-monopoly law-enforcement ecosystem: TASER devices, body cameras, and Evidence.com cloud software. That creates high switching costs and a recurring-revenue base, now extended by AI (Draft One), drones, real-time crime centers, and enterprise and international expansion. It is still a high-growth franchise with a long reinvestment runway, but heavy stock-based compensation keeps GAAP margins far below what the gross margin and software mix imply.
Most drivers are unchanged from the 2026-09-09 take. Year-1 growth moves from 22% to 24% (not a material change) because TTM revenue of 3.22B shows growth still running near 30%. The 22% target margin assumes SBC dilution fades as the software mix scales, and the observed 1.4 sales-to-capital should improve toward 1.8 as cloud revenue compounds.
Value drivers
| Revenue growth (Y1) | 24.0% |
| Terminal growth | 3.0% |
| Forecast horizon | 10y |
| Target operating margin | 22.0% |
| Years to target margin | 7 |
| Sales-to-capital | 1.80 |
| Beta | 1.15 |
| Failure probability | 5.0% |
| Cost of capital (WACC) | 10.2% |
| Terminal WACC | 9.5% |
Valuation bridge
| PV of explicit FCFF | 5.42B |
| PV of terminal value | 11.33B |
| Equity value | 15.34B |
| ÷ shares → per share | $188.77 |
News
bearish -0.30 · 8 articles
- Axon Enterprise (AXON) Stock Sinks As Market Gains: What You Should Know
- Sterling, Axon, Herc, Nextpower, and FTAI Aviation Shares Plummet, What You Need To Know
- Axon Enterprise (AXON) Suffers a Larger Drop Than the General Market: Key Insights
- 3 Reasons AXON Has Explosive Upside Potential
- Axon Stock Just Fell 22% in a Month. Here’s the Number That Explains Why
- Axon Enterprise (AXON) Prices $1B of Zero-Coupon Notes. What is the Real Cost?
- Axon (AXON) Stock Looks Fairly Valued As 149% Run Meets Funding Test
- Stocks making big moves this week: Sabre, DocuSign, Dave & Buster's, RUM Group, and Axon
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 3.99B | 24.0% | 11.0% | 440.96M | 429.21M | 11.74M | 10.66M |
| 2 | 4.86B | 21.7% | 12.9% | 625.16M | 480.48M | 144.68M | 119.18M |
| 3 | 5.80B | 19.3% | 14.7% | 851.82M | 521.63M | 330.19M | 246.86M |
| 4 | 6.78B | 17.0% | 16.5% | 1.12B | 547.35M | 573.06M | 388.85M |
| 5 | 7.78B | 14.7% | 18.3% | 1.43B | 552.50M | 874.17M | 538.37M |
| 6 | 8.73B | 12.3% | 20.2% | 1.76B | 532.75M | 1.23B | 687.15M |
| 7 | 9.61B | 10.0% | 22.0% | 2.11B | 485.23M | 1.63B | 826.13M |
| 8 | 10.34B | 7.7% | 22.0% | 2.28B | 409.21M | 1.87B | 859.42M |
| 9 | 10.90B | 5.3% | 22.0% | 2.40B | 306.49M | 2.09B | 873.66M |
| 10 | 11.22B | 3.0% | 22.0% | 2.47B | 181.60M | 2.29B | 867.59M |
Key risks
- SBC-heavy GAAP margins (4.1% to 9.2%) may never converge to the adjusted-margin narrative
- Municipal and federal budget pressure, or procurement and antitrust scrutiny of bundled contracts
- Valuation near 11x sales leaves no room for a growth deceleration or execution misses on new products
Catalysts
- Evidence of GAAP operating leverage as SBC growth slows relative to revenue
- AI, drone, and enterprise bookings converting into accelerating ARR and international wins